MedPath

Effects of N-acetylcysteine administration in treatment of women with gestational diabetes mellitus

Phase 3
Conditions
Gestational diabetes mellitus.
Unspecified diabetes mellitus in pregnancy, childbirth and the puerperium
O24.9
Registration Number
IRCT20170513033941N71
Lead Sponsor
Kashan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
76
Inclusion Criteria

Women with gestational diabetes mellitus.
Individuals aged 18 to 40 years.

Exclusion Criteria

Overt diabetes mellitus
Taking any antioxidant agents 3 months before the intervention
Needing insulin therapy
Hypo and hyperthyroidism
Unwillingness to cooperate

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin resistance. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Calculation using HOMA formula.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath